Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
Since 1953, we've led the field with support for immunotherapy research and clinical trials. Together with our donor, patient, and scientist communities, we continue to fund revolutionary breakthroughs to cure all types of cancer.
By harnessing the innate powers of the body's immune system, immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cures for all types of cancer.
See how immunotherapy works
See Where Your Money Goes
Fundraise for immunotherapy
Share Stories and Connect
Become a corporate sponsor
National Headquarters | One Exchange Plaza
55 Broadway, Suite 1802 | New York, NY 10006
(800) 992-2623(212) 832-9376Staff Directory
Pembrolizumab is second anti-PD-1 drug approved for adults with cHL, first for any childhood cancer
March is Colorectal Cancer Awareness Month, and the need for a spotlight on this disease is as urgent as ever.